Global Blood Therapeutics, Inc.
GBTDelisted Oct 5, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001629137
Global Blood Therapeutics, Inc. was delisted on Oct 5, 2022; its insiders filed their last Form 4 on Oct 6, 2022; 247 institutions reported holding it in 13F filings for Q3 2022, worth $4.67B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding GBT, Q3 2022
1 superinvestor reports holding Global Blood Therapeutics, Inc. on Form 13F, worth $0 in total. Weight is Global Blood Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q2 2022.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 0.0% | 1 | $0 | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of GBT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2022
1 superinvestor holding at quarter end